Literature DB >> 35869758

[Vasohibin-2 promotes proliferation and metastasis of cervical cancer cells by regulating epithelial-mesenchymal transition].

J Wang1, C Yu1, X Jiang1, X Wu1, Y Jia1, H Zhang1, Z Li1.   

Abstract

OBJECTIVE: To explore the role of vasohibin-2 (VASH2) in regulation of proliferation and metastasis of cervical cancer cells.
METHODS: We analyzed the differentially expressed genes between cervical cancer cells with flotillin-1 overexpression and knockdown by RNA-seq combined with analysis of public databases. The expression levels of VASH2 were examined in normal cervical epithelial cells (HcerEpic), cervical cancer cell lines (HeLa, C-33A, Ca ski, SiHa and MS751) and fresh cervical cancer tissues with different lymph node metastasis status. We further tested the effects of lentivirus-mediated overexpression and interference of VASH2 on proliferation, migration, invasion and lymphatic vessel formation of the cervical cancer cells and detected the expression levels of key epithelial-mesenchymal transition (EMT) markers and TGF-β mRNA.
RESULTS: RNA-seq and analysis of public databases showed that VASH2 expression was significantly upregulated in cervical cancer cells exogenously overexpressing flotillin-1 (P < 0.05) and downregulated in cells with flotillin-1 knockdown (P < 0.05), and was significantly higher in cervical cancer tissues with lymph node metastasis than in those without lymph node metastasis (P < 0.01). In cervical cancer cell lines Ca Ski, SiHa, and MS751 and cervical cancer tissue specimens with lymph node metastasis, VASH2 expression was also significantly upregulated as compared with HcerEpic cells and cervical cancer tissues without lymph node metastasis (P < 0.05). Exogenous overexpression of VASH2 significantly promoted proliferation, migration, invasion and lymphatic vessel formation of cervical cancer cells, whereas these abilities were significantly inhibited in cells with VASH2 knockdown (P < 0.05). The cervical cancer cells overexpressing VASH2 showed significant down- regulation of e-cadherin and up- regulation of N-cadherin, Vimentin and VEGF-C, while the reverse changes were detected in cells with VASH2 knockdown (P < 0.05). TGF-β mRNA expression was significantly up-regulated in cervical cancer cells overexpressing VASH2 and down-regulated in cells with VASH2 knockdown (P < 0.001).
CONCLUSION: Flotillin-1 may participate in TGF-β signaling pathway-mediated EMT through its down-stream target gene VASH2 to promote the proliferation, migration, invasion and lymphatic vessel formation of cervical cancer cells in vitro.

Entities:  

Keywords:  cell proliferation; cervical cancer; epithelial-mesenchymal transition; flotillin- 1; tumor metastasis; vasohibin- 2

Mesh:

Substances:

Year:  2022        PMID: 35869758      PMCID: PMC9308866          DOI: 10.12122/j.issn.1673-4254.2022.07.02

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  33 in total

1.  Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.

Authors:  Yoshifumi Takahashi; Takahiro Koyanagi; Yasuhiro Suzuki; Yasushi Saga; Naoki Kanomata; Takuya Moriya; Mitsuaki Suzuki; Yasufumi Sato
Journal:  Mol Cancer Res       Date:  2012-07-23       Impact factor: 5.852

Review 2.  Angiopoietin inhibitors: A review on targeting tumor angiogenesis.

Authors:  Digna Parmar; Madhavi Apte
Journal:  Eur J Pharmacol       Date:  2021-03-16       Impact factor: 4.432

3.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

Review 4.  Pelvic and aortic lymphadenectomy in cervical cancer: the standardization of surgical procedure and its clinical impact.

Authors:  Pierluigi Benedetti Panici; Stefano Basile; Roberto Angioli
Journal:  Gynecol Oncol       Date:  2009-01-21       Impact factor: 5.482

5.  Elevated expression of flotillin-1 is associated with lymph node metastasis and poor prognosis in early-stage cervical cancer.

Authors:  Zheng Li; Yang Yang; Yang Gao; Xiaoliu Wu; Xielan Yang; Yingjie Zhu; Hongying Yang; Lin Wu; Chengang Yang; Libing Song
Journal:  Am J Cancer Res       Date:  2015-12-15       Impact factor: 6.166

6.  Quaking 5 suppresses TGF-β-induced EMT and cell invasion in lung adenocarcinoma.

Authors:  Shengjie Wang; Xin Tong; Chang Li; Ersuo Jin; Zhiyue Su; Zelong Sun; Weiwei Zhang; Zhe Lei; Hong-Tao Zhang
Journal:  EMBO Rep       Date:  2021-03-26       Impact factor: 8.807

Review 7.  Research advances on flotillins.

Authors:  Feng Zhao; Jie Zhang; Yong-Sheng Liu; Li Li; Ya-Li He
Journal:  Virol J       Date:  2011-10-25       Impact factor: 4.099

8.  Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis.

Authors:  Shuji Kitahara; Yasuhiro Suzuki; Masae Morishima; Asuka Yoshii; Sachiko Kikuta; Kazuhiko Shimizu; Shunichi Morikawa; Yasufumi Sato; Taichi Ezaki
Journal:  Mol Cancer       Date:  2014-05-04       Impact factor: 27.401

9.  Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.

Authors:  Rie Norita; Yasuhiro Suzuki; Yutaka Furutani; Kazuki Takahashi; Yasuhiro Yoshimatsu; Katarzyna A Podyma-Inoue; Tetsuro Watabe; Yasufumi Sato
Journal:  Cancer Sci       Date:  2017-03       Impact factor: 6.716

10.  High expression of PTPRM predicts poor prognosis and promotes tumor growth and lymph node metastasis in cervical cancer.

Authors:  Pan Liu; Chunyu Zhang; Yuandong Liao; Junxiu Liu; Jiaming Huang; Meng Xia; Ming Chen; Hao Tan; Weipeng He; Manman Xu; Tianyu Liu; Shiyin Ooi; Qiqiao Du; Shuhang Qin; Yuan Zhu; Qiaojian Zou; Wei Wang; Shuzhong Yao
Journal:  Cell Death Dis       Date:  2020-08-11       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.